Ethema Health (OTCMKTS:GRST) vs. BioNexus Gene Lab (NASDAQ:BGLC) Head-To-Head Review

BioNexus Gene Lab (NASDAQ:BGLC) and Ethema Health (OTCMKTS:GRST) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends.

Institutional & Insider Ownership

18.9% of BioNexus Gene Lab shares are owned by institutional investors. 0.1% of BioNexus Gene Lab shares are owned by company insiders. Comparatively, 55.8% of Ethema Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and target prices for BioNexus Gene Lab and Ethema Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNexus Gene Lab	1	0	0	0	1.00
Ethema Health	0	0	0	0	0.00

Profitability

This table compares BioNexus Gene Lab and Ethema Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioNexus Gene Lab	-40.19%	-38.85%	-33.36%
Ethema Health	-9.35%	N/A	-5.77%

Valuation and Earnings

This table compares BioNexus Gene Lab and Ethema Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNexus Gene Lab	$7.43 million	0.72	-$2.98 million	($1.28)	-1.73
Ethema Health	$6.02 million	0.13	-$2.06 million	N/A	N/A

Ethema Health has lower revenue, but higher earnings than BioNexus Gene Lab.

Risk and Volatility

BioNexus Gene Lab has a beta of 4.98, suggesting that its share price is 398% more volatile than the S&P 500. Comparatively, Ethema Health has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

About Ethema Health

Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.